Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

his endpoint, significant slowing of disease was seen, with regression in 23% of patients treated with lovastatin compared to 11% of placebo patients.

In the Familial Atherosclerosis Treatment Study (FATS), either lovastatin or niacin in combination with a bile acid sequestrant for 2.5 years in hyperlipidemic subjects significantly reduced the frequency of progression and increased the frequency of regression of coronary atherosclerotic lesions by QCA compared to diet and, in some cases, low-dose resin.

The effect of lovastatin on the progression of atherosclerosis in the coronary arteries has been corroborated by similar findings in another vasculature. In the Asymptomatic Carotid Artery Progression Study (ACAPS), the effect of therapy with lovastatin on carotid atherosclerosis was assessed by B-mode ultrasonography in hyperlipidemic patients with early carotid lesions and without known coronary heart disease at baseline. In this double-blind, controlled clinical trial, 919 patients were randomized in a 2 x 2 factorial design to placebo, lovastatin 10-40 mg daily and/or warfarin. Ultrasonograms of the carotid walls were used to determine the change per patient from baseline to three years in mean maximum intimal-medial thickness (IMT) of 12 measured segments. There was a significant regression of carotid lesions in patients receiving lovastatin alone compared to those receiving placebo alone (p=0.001). The predictive value of changes in IMT for stroke has not yet been established. In the lovastatin group there was a significant reduction in the number of patients with major cardiovascular events relative to the placebo group (5 vs. 14) and a significant reduction in all-cause mortality (1 vs. 8).

Eye

There was a high prevalence of baseline lenticular opacities in the patient population included in the early clinical trials with lovastatin. During these trials the appearance of new opacities was noted in both the lovastatin and placebo gr
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Longmont, Colo. (PRWEB) July 31, 2014 ... snacks, has launched three new products including: a Cacao Nib ... Like all Two Moms in the Raw products, each is ... , “My family is picky, so I’m constantly working on ... our consumers more healthy and tasty choices,” said Shari Leidich, ...
(Date:7/31/2014)... Ohio Presbyterian Retirement Services (OPRS) announced that ... Center, Inc. (Sarah Moore HCC) has joined its family ... Sarah Moore HCC was established in 1892 as a home ... has grown and developed an excellent reputation for high-quality assisted ... has been an integral part of the Delaware community for ...
(Date:7/31/2014)... Francsico, CA (PRWEB) July 31, 2014 ... Sweden have published the largest study ... triage through either teledermoscopy or traditional letter referral ... that smartphone referrals via patent pending iDoc24® technology ... patients with skin cancer while potentially eliminating unnecessary ...
(Date:7/31/2014)... Glaser Pediatric AIDS Foundation (EGPAF) and Riders for ... the delivery of laboratory samples and HIV-related test ... the Northern and Central Zones of Malawi. ... will establish a dependable and coordinated system to ... in health services for the more than 1.3 ...
(Date:7/31/2014)... Delhi, India (PRWEB) July 31, 2014 ... special service for those individuals and organizations against whom ... service as ‘Remove Negative Comments Service’. , About ... said, “We have officially announced the service now, but ... get rid of negative comments for several years.” , ...
Breaking Medicine News(10 mins):Health News:Two Moms in the Raw Launches Three New, Raw, Sprouted 100% Organic Snacks 2Health News:Two Moms in the Raw Launches Three New, Raw, Sprouted 100% Organic Snacks 3Health News:Ohio Presbyterian Retirement Services Welcomes The Sarah Moore HCC into Its Family 2Health News:Ohio Presbyterian Retirement Services Welcomes The Sarah Moore HCC into Its Family 3Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 2Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 3Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 4Health News:Elizabeth Glaser Pediatric AIDS Foundation partners with Riders for Health in Malawi 2Health News:RankingBySEO Launches a New Service ‘Remove Negative Comments’ 2
... must stop tippling if they want to recover from ... that researched the brain's capacity to regenerate.// ... provides evidence that excessive drinking for a long period ... portal EurekAlert. ,During abstinence, an alcoholic's brain ...
... and literature to spread awareness about the importance of ... including 6,000 women scholars, will be appointed to spread ... said Chaudhry Shahbaz Hussain, federal population planning minister. ... students also aware of these norms, he said. ...
... next-generation medical technology, in conjunction with MYOTECH//, LLC, ... the potential of the MYO-VAD, a cardiac support ... failure. The MYO-VAD restores cardiac output on an ... implanted in approximately three minutes. ,Researchers found ...
... Supermarket chains are recalling some brands of frozen ready meals ... Eye meals//, because of fears that they may contain small ... thousands of ready meals. ,The products came ... Group. Rye Valley foods are one of the country's biggest ...
... from the Italian court, presiding over a milestone case regarding ... paralyzed and terminally ill – who has petitioned the court ... and allow him to die. ,Italy, largely influenced ... and the case has stirred a hornet’s nest, where euthanasia ...
... cells have the ability to trace damaged tissue in the ... on mice.// ,This finding is of great interest ... the human brain, and this knowledge can be put to ... disorders such as traumatic injury. ,Dr. Chay Kuo, ...
Cached Medicine News:Health News:Positive Animal Study on MYO-VAD, Promise for Treatment of Heart Failure 2Health News:Stem Cells In Brain Have Potential For Sensing Damage And To Repair 2
(Date:7/31/2014)... July 31, 2014  Zacks.com announces the list of stocks ... Research analysts discuss the latest news and events impacting stocks ... include the Biogen (Nasdaq: BIIB - Free Report ), Gilead ... PBYI - Free Report ), AbbVie (NYSE: ABBV ... Free Report ). Today, Zacks is promoting its ...
(Date:7/31/2014)... YORK , July 31, 2014 TB ... better, faster and affordable treatments for tuberculosis (TB), announced ... Vice President, Market Access. Ms. Robertson joins the organization ... company,s business in Sub-Saharan Africa and Eastern ... oversee the TB Alliance,s efforts to ensure beneficial new ...
(Date:7/31/2014)... und KISSING, Deutschland, 31. Juli ... und Distributor eines computerunterstützten („robotischen") Koloskopie-Systems für ... (Homi) Shamir , ein weltweit anerkannter Manager ... und Kontrollgremiums zum Unternehmen stößt. ... Shamir ist ein hochangesehener globaler Visionär ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6TB Alliance Names Elana Robertson Senior Vice President, Market Access 2TB Alliance Names Elana Robertson Senior Vice President, Market Access 3invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3
... 4, 2011 Bioness Inc. today ... of the FASTEST study to further examine the impact of ... drop as a result of stroke. The FASTEST study aims ... System over standard therapy with an ankle-foot orthosis (AFO), and ...
... Inc. (NASDAQ: NBIX ) today announced that it ... for elagolix and next-generation Gonadotropin Releasing Hormone (GnRH) Receptor Antagonists. ... with the FDA, the outcome of which generated a $20 ... event brings the total milestones achieved by the Company in ...
Cached Medicine Technology:Bioness Inc. Announces Completion of Enrollment in Its FASTEST L300 Study 2Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement 2
Hand surgery basic instrument set with round handled instruments...
Rhoton microscopic forceps, straight...
Quick release, easy to close 2" webbing and buckle. Available in teal, royal, red, purple, and maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Velcro closures on each side to more evenly distribute the weight. Available in teal, royal, red, purple, or maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Medicine Products: